A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as effectively as standard hormone injections in men with locally advanced or ...

Telix to partner with companies developing advanced minimally invasive and image-guided ablative technologies for prostate cancer.Initial focus ...

Olympus has signed a definitive agreement to acquire BioProtect for $270 million, adding biodegradable balloon spacer ...

A BREAKTHROUGH discovery could see HIV patients be drug-free for up to two years, removing the need for daily pills, a trial ...

Detailed price information for Shanghai Fosun Pharm Reg (SFOSF) from The Globe and Mail including charting and trades.

Leading particle accelerator company expands portfolio of positron emission tomography diagnostics LANSING, Mich., May 26, 2026 (GLOBE ...

Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...

An investigator presented extended follow-up data from a phase 3 trial on aglatimagene besadenovec (CAN-2409) + prodrug in combination with standard-of-care EBRT in men with localized prostate cancer.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

Upcoming presentations at the ASCO meeting in Chicago highlight potential practice-changing studies in cancer care.

Telemedicine can absolutely be an effective way to deliver TRT when performed responsibly, agrees Dr. Miller. “In many ways, ...

In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...